GleamWall
中文EN

APHD VERDE BIO HOLDINGS, INC.

Crude Petroleum & Natural Gas · OTC · SEC CIK 1490054 · Fiscal year ends 04/30

Financial factors as of 2024-01-31 (2024Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-45.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-190.1%
ROA-85.1%
ROIC (approx.)-83.9%
Asset turnover—

Leverage & solvency

Liabilities / assets84.8%
Debt / equity0.00x
Current ratio—
Interest coverage-38.29x

Cash quality & payout

Operating cash flow / net income0.42x
Accruals ratio-49.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20232023-04-30FY20222022-04-30
Income statement
Revenue——
Operating income-$1.64M-$3.15M
Interest expense$65,878$0
Pretax income-$1.77M-$3.42M
Income tax$0$0
Net income-$1.86M-$3.44M
EBITDA-$1.58M-$3.12M
EPS (basic)—0.00
EPS (diluted)—0.00
Weighted avg. shares (diluted)—1.14B
Balance sheet
Cash & equivalents$25,836$141,206
Receivables$71,912—
Current assets$97,748$295,873
PP&E, net$2.72M$2.78M
Total assets$4.16M$5.09M
Current liabilities$1.84M$1.45M
Total liabilities$1.84M$1.47M
Shareholders' equity$2.21M$3.59M
Shares outstanding1.54B1.18B
Cash flow statement
Operating cash flow-$872,226-$1.15M
Capital expenditure$6,985$2.87M
Free cash flow-$879,211-$4.02M
Investing cash flow$148,015-$5.68M
Financing cash flow$608,841$4.88M
Depreciation & amortization$61,583$25,874

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.